市場調查報告書
商品編碼
1463735
到 2030 年北美減重手術市場預測 - 區域分析 - 按類型和最終用戶(醫院和門診手術中心)North America Bariatric Surgeries Market Forecast to 2030 - Regional Analysis - by Type and End User (Hospitals and Ambulatory Surgical Centers) |
2022年北美減重手術市場價值為47.7565億美元,預計到2030年將達到152.8779億美元;預計2022年至2030年CAGR為15.7%。
肥胖盛行率的增加推動了北美減重手術市場
體內脂肪堆積過多被稱為肥胖,它會導致各種健康問題。當體重指數為25或以上時,就被認為是肥胖。肥胖是心血管疾病和糖尿病等各種健康狀況的主要原因之一。飲食習慣和久坐生活方式的改變增加了全球肥胖的盛行率。很大一部分人食用高熱量、高脂肪食物而體力活動有限,導致肥胖率增加。據世界衛生組織稱,到 2022 年,全球約有 10 億人肥胖,其中包括 3,900 萬兒童、3.4 億青少年和 6.5 億成年人。有多種因素會影響體重並導致肥胖,例如遺傳、行為、代謝和荷爾蒙。在某些情況下,肥胖可能是由醫學原因引起的,例如甲狀腺功能減退症、庫欣氏症候群和普瑞德威利症候群。肥胖症的日益普及導致了各種健康問題。大多數肥胖者因社會孤立、殘疾和工作成就較低而感到沮喪、羞恥和內疚,這影響了他們的生活品質。根據國家老化委員會 (NCOA) 2021 年報告,體重超重的成年人一生中患憂鬱症的風險比未患有肥胖症的人高 55%。
為了克服上述條件並提高廣大人口對肥胖後果的認知,對減重手術的需求正在增加,因為它有助於減輕體重。根據美國代謝和減肥外科學會的數據,2021 年美國總共進行了 262,893 例減肥手術,而 2020 年美國則進行了 198,651 例手術。因此,肥胖盛行率的增加以及對其後果的認知不斷提高,增加了對減重手術的需求,推動了減重手術設備市場的發展。
北美減肥手術市場概況
根據美國、加拿大和墨西哥對北美減肥手術市場進行了分析。該地區的市場成長歸因於肥胖人數的增加、產品批准的增加、減肥手術意識的增強以及營運商之間合併、合作和夥伴關係數量的增加。此外,肥胖相關合併症的發生率顯著增加是減重手術需求增加的其他主要因素之一。由於胃束帶和氣球以及上述其他外科手術等技術的進步,美國的減重手術設備已顯著成長。一些市場參與者正在採取有機策略來保持市場競爭力。例如,2021 年 5 月,Standard Bariatrics 宣布其新型 Titan SGS 吻合技術已獲得美國食品藥物管理局 (FDA) 的批准,該技術專為減肥袖狀手術而設計。 Titan SGS 為執行袖狀胃切除手術的外科醫生提供了業界最長的 23 公分連續吻合釘切割線。
北美減重手術市場收入和 2030 年預測(百萬美元)
北美減重手術市場細分
北美減重手術市場按類型、最終用戶和國家進行細分。
根據類型,北美減重手術市場分為可調式胃帶(AGB)、袖狀胃切除術、胃繞道術、十二指腸開關膽胰分流術(bpd-ds)等。 2022 年,袖狀胃切除術細分市場佔據最大佔有率。
就最終用戶而言,北美減重手術市場分為醫院和門診手術中心。 2022 年,醫院細分市場將佔據更大佔有率。
根據國家/地區,北美減肥手術市場分為美國、加拿大和墨西哥。 2022 年,美國主導北美減重手術市場。
Apollo Endosurgery Inc、Conmed Corp、Ethicon USA LLC、Integra LifeSciences Holdings Corp、Intuitive Surgical Inc、Medtronic Plc、Olympus Corp、Reshape Lifesciences Inc 和 Spatz FGIA Inc 是北美減肥手術市場的一些領先公司。
表中的內容
The North America bariatric surgeries market was valued at US$ 4,775.65 million in 2022 and is expected to reach US$ 15,287.79 million by 2030; it is estimated to grow at a CAGR of 15.7% from 2022 to 2030.
Increasing Prevalence of Obesity Fuels the North America Bariatric Surgeries Market
Excess amount of fat accumulation in the body is known as obesity, which can cause various health problems. When the body mass index is 25 or above, it is considered obesity. Obesity is one of the leading causes of various health conditions, such as cardiovascular disorders and diabetes. Changes in food habits and sedentary lifestyles have increased the prevalence of obesity on a global level. A large percentage of the population consuming high-calorie, high-fat food with limited physical activity has increased obesity rates. According to the World Health Organization, in 2022, ~1 billion people worldwide were obese, including 39 million children, 340 million adolescents, and 650 million adults. There are various factors, such as genetic, behavioral, metabolic, and hormonal, that influence body weight and can cause obesity. In some cases, obesity can be caused due to medical reasons such as hypothyroidism, Cushing syndrome, and Prader-Willi syndrome. The increasing prevalence of obesity leads to various health concerns. Most of the obese population experience depression, shame, and guilt about their social isolation, disability, and lower work achievement, which affects their quality of life. According to the National Council of Aging (NCOA) 2021 report, adults with excess weight had a 55% higher risk of developing depression in their lifetime than those who did not suffer from obesity.
To overcome the abovementioned conditions and increase awareness among large populations about the consequences of obesity, the demand for bariatric surgery is increasing as it helps in weight reduction. According to the American Society for Metabolic and Bariatric Surgery, there were a total of 262,893 bariatric surgeries performed in 2021 as compared to 198,651 surgeries in 2020 in the US. Therefore, increasing prevalence of obesity and rising awareness about its consequences have increased the demand for bariatric surgeries, driving the bariatric surgery devices market.
North America Bariatric Surgeries Market Overview
The North America bariatric surgeries market is analyzed based on the US, Canada, and Mexico. The market growth in the region is attributed to increasing obesity, rising product approvals, growing awareness about bariatric surgeries, and rising number of mergers, collaborations, and partnerships among the operating players. In addition, significantly growing incidences of obesity associated comorbidity are among the other leading factors escalating the demand for bariatric surgeries. Bariatric surgery devices in the US have grown significantly owing to advancements in technologies such as gastric bands & balloons and other surgical procedures mentioned above. Several market players are adopting organic strategies to stay competitive in the market. For instance, in May 2021, Standard Bariatrics announced that it had been cleared by the US Food and Drug Administration (FDA) for its novel Titan SGS stapling technology, designed precisely for bariatric sleeve surgery. The Titan SGS offers surgeons performing sleeve gastrectomy procedures the industry's longest continuous staple cutline of 23 cm.
North America Bariatric Surgeries Market Revenue and Forecast to 2030 (US$ Million)
North America Bariatric Surgeries Market Segmentation
The North America bariatric surgeries market is segmented into type, end user, and country.
Based on type, the North America bariatric surgeries market is categorized adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (bpd- ds), and others. The sleeve gastrectomy market segment held the largest share in 2022.
In terms of end user, the North America bariatric surgeries market is bifurcated into hospitals and ambulatory surgical centers. The hospitals segment held a larger share in 2022.
Based on country, the North America bariatric surgeries market is segmented the US, Canada, and Mexico. The US dominated the North America bariatric surgeries market in 2022.
Apollo Endosurgery Inc, Conmed Corp, Ethicon USA LLC, Integra LifeSciences Holdings Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, Reshape Lifesciences Inc, and Spatz FGIA Inc are some of the leading companies operating in the North America bariatric surgeries market.
Table of Content